Medtronic is nearing a U.S. launch for its Hugo surgical robot more than three years after receiving approval to release the soft tissue system in Europe. CEO Geoff Martha told investors Tuesday ...

Medtronic’s potential rivalry in US market Medtronic’s Hugo robot poses the main challenge to da Vinci given the company's size. Hugo has been in use in Europe since 2022 and the company ...

Notably, Medtronic has finished enrolling patients in a U.S. study of its surgical robot, Hugo. The company is studying Hugo in patients who need hernia surgeries and benign hysterectomies.

Medtronic is making major moves with its Hugo surgical robot platform to submit for the FDA approval in 2025. MDT currently trails Intuitive Surgical in this niche, but the roll-out of the Hugo ...

Recent gains from Medtronic (MDT -7%) are being cut into today despite the ... MDT noted that utilization is continuing to increase overseas, with Hugo procedure volumes doubling yr/yr. Hugo is MDT's ...

A clinician uses Medtronic's pulsed field ablation system for treating atrial fibrillation last month. On Tuesday, Medtronic reported adjusted quarterly net profit of $1.8 billion on $8.3 billion ...

the Hugo System, for an area that remains deeply underpenetrated. Both of these niches could represent powerful, long-term tailwinds for the company. Furthermore, Medtronic is implementing ...

VCG / Contributor / Getty Images Medtronic shares slumped Tuesday after the medical device maker missed sales forecasts. The revenue miss came as sales of its stapling and blood oxygen management ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...